Encompass Health Boosts Full-Year Outlook on Strong Q2 Growth — Encompass Health Corp.

Event summary

Encompass Health reported Q2 2026 revenue growth of 9.6%, with net operating revenue reaching $1,597.4 million.
Adjusted EBITDA increased by 9.2% to $348.0 million, while adjusted earnings per share grew by 10.7% to $1.55.
The company opened three new hospitals and added 54 beds to existing facilities in the first half of 2026.
Full-year guidance was raised, with net operating revenue now expected between $6,410 million and $6,490 million.
Board approved a $1 billion increase in common stock repurchase authorization.

The big picture

Encompass Health's strong Q2 performance and raised full-year guidance reflect its strategic focus on expanding access to high-quality inpatient rehabilitation care. The company's disciplined operating strategy and optimistic long-term outlook are validated by its ability to grow revenue and EBITDA despite a competitive healthcare landscape. The increased stock repurchase authorization signals confidence in the company's financial health and future prospects.

What we're watching

Expansion Strategy: The pace at which Encompass Health can successfully open five additional hospitals and add more than 100 beds to existing facilities before year-end.
Financial Performance: Whether the company can sustain its strong revenue growth and EBITDA margins in the face of potential economic headwinds.
Capital Allocation: How the increased stock repurchase authorization will impact shareholder value and the company's financial flexibility.